Molecular modification of T4 bacteriophage proteins and its potential application - review
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- bakteriofág T4 chemie genetika metabolismus MeSH
- biotechnologie * MeSH
- peptidová knihovna MeSH
- virové proteiny chemie genetika metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- peptidová knihovna MeSH
- virové proteiny MeSH
Bacteriophage T4 is a virus with well-known genetics, structure, and biology. Such techniques as X-ray crystallography, cryo-EM, and three-dimensional (3D) image reconstruction allowed describing its structure very precisely. The genome of this bacteriophage was completely sequenced, which opens the way for the use of many molecular techniques, such as site-specific mutagenesis, which was widely applied, e.g., in investigating the functions of some essential T4 proteins. The phage-display method, which is commonly applied in bacteriophage modifications, was successfully used to display antigens (PorA protein, VP2 protein of vvIBDV, and antigens of anthrax and HIV) on T4's capsid platform. As first studies showed, the phage-display system as well as site-specific mutagenesis may also be used to modify interactions between phage particles and mammalian cells or to obtain phages infecting species other than the host bacteria. These may be used, among others, in the constantly developing bacteriophage therapy. All manipulations of this popular bacteriophage may enable the development of vaccine technology, phage therapy, and other branches of biological and medical science.
Zobrazit více v PubMed
Trends Microbiol. 2006 Mar;14(3):141-7 PubMed
J Biol Chem. 1984 Feb 10;259(3):1539-45 PubMed
Arch Microbiol. 2007 Jun;187(6):489-98 PubMed
Lancet. 2000 Oct 21;356(9239):1418 PubMed
Antimicrob Agents Chemother. 2001 Mar;45(3):649-59 PubMed
Virology. 2001 Jan 20;279(2):385-91 PubMed
Virus Genes. 1995;10(2):173-7 PubMed
J Bacteriol. 1989 May;171(5):2265-70 PubMed
J Mol Biol. 1994 Aug 26;241(4):524-33 PubMed
Arch Virol. 1997;142(12):2329-45 PubMed
Biotechnol Adv. 2001 Feb 1;19(1):1-33 PubMed
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1622-54 PubMed
Science. 2002 Oct 25;298(5594):728-31 PubMed
J Mol Biol. 1991 Nov 5;222(1):67-88 PubMed
Gene. 1998 Jul 30;215(2):439-44 PubMed
Virus Genes. 1997;14(2):163-5 PubMed
Biochim Biophys Acta. 2000 Mar 6;1474(1):107-13 PubMed
Nat Med. 2006 Jun;12(6):600-1 PubMed
Biochemistry (Mosc). 2004 Nov;69(11):1190-202 PubMed
Science. 1985 Jun 14;228(4705):1315-7 PubMed
J Biotechnol. 2005 Jan 12;115(1):101-7 PubMed
J Biol Chem. 1993 Jan 15;268(2):880-6 PubMed
Plant Mol Biol. 2002 Dec;50(6):837-54 PubMed
Adv Drug Deliv Rev. 2000 Sep 30;43(2-3):165-96 PubMed
Proc Natl Acad Sci U S A. 1975 Sep;72(9):3701-5 PubMed
Trends Biotechnol. 2003 Sep;21(9):408-14 PubMed
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6003-8 PubMed
J Biol Chem. 1988 Aug 15;263(23):11336-47 PubMed
J Biol Chem. 1995 Mar 10;270(10):5107-14 PubMed
Virology. 2001 Mar 30;282(1):102-12 PubMed
J Bacteriol. 1990 Jun;172(6):3037-9 PubMed
Appl Microbiol Biotechnol. 2006 Mar;70(1):2-11 PubMed
Vaccine. 2007 Jan 26;25(7):1225-35 PubMed
Anticancer Res. 2004 Nov-Dec;24(6):3991-5 PubMed
Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples
Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report
